First Pacific Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9K Sell
339
-9,986
-97% -$460K ﹤0.01% 383
2026
Q2
$495K Buy
10,325
+35
+0.3% +$1.5K 0.06% 130
2026
Q1
$378K Buy
10,290
+484
+5% +$22.9K 0.05% 143
2025
Q4
$499K Sell
9,806
-1,385
-12% -$70.8K 0.07% 127
2025
Q3
$621K Buy
11,191
+360
+3% +$21.1K 0.09% 115
2025
Q2
$748K Sell
10,831
-1,023
-9% -$69.6K 0.11% 102
2025
Q1
$823K Buy
+11,854
New +$979K 0.17% 71

Other funds holding NVO

First Pacific Financial's NVO Position: Q3 2026 in Review

First Pacific Financial reduced its Novo Nordisk (NVO) stake by 97% in Q3 2026, selling an estimated $460K and leaving 339 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #383.

First Pacific Financial first reported a position in NVO in Q1 2025 and has held it in 7 quarters since. The position peaked at $823K in Q1 2025. 1,220 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • First Pacific Financial held 339 shares of Novo Nordisk worth $12.9K as of Q3 2026.
  • First Pacific Financial sold 9,986 Novo Nordisk shares in Q3 2026, an estimated $460K.
  • Novo Nordisk made up ﹤0.01% of First Pacific Financial's portfolio in Q3 2026, its #383 holding.
  • First Pacific Financial first reported a position in Novo Nordisk in Q1 2025 and has held it in 7 quarters since.
  • First Pacific Financial's Novo Nordisk position peaked at $823K in Q1 2025.
  • 1,220 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on First Pacific Financial's 13F filing for Q3 2026, filed 14 Oct 2026.